|
⚲
|
| Keyboard |
| Bernales Sebastian
✚
|
|
|---|---|
| CIK # | 0001995659 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001995659] | |
| 4 | [0001995659] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Metagenomi Therapeutics Inc | |
| Bernales Sebastian |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Metagenomi Therapeutics Inc MGX
Stock Option (Right to Buy) · derivative
|
2024-04-01 | Grant | 78,636 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Common Stock
|
2024-02-13 | Conversion | 1,896,445 | ||
|
Metagenomi Therapeutics Inc MGX
Series A-3 Preferred Stock · derivative
|
2024-02-13 | Conversion | 119,699 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Series A-4 Preferred Stock · derivative
|
2024-02-13 | Conversion | 423,469 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Common Stockc
|
2024-02-13 | Conversion | 513,004 | ||
|
Metagenomi Therapeutics Inc MGX
Series B Preferred Stock · derivative
|
2024-02-13 | Conversion | 1,143,905 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Series B-1 Preferred Stock · derivative
|
2024-02-13 | Conversion | 106,627 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Series A-2 Preferred Stock · derivative
|
2024-02-13 | Conversion | 353,005 | $0.00 | |
|
Metagenomi Therapeutics Inc MGX
Series A-4 Preferred Stock · derivative
|
2024-02-13 | Conversion | 2,062,387 | $0.00 |